Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperglycemia × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 59 Breast Neoplasms 45 Myelodysplastic Syndromes 25 Neoplasms 23 Advanced Solid Tumor 22 Carcinoma, Non-Small-Cell Lung 21 Advanced Solid Tumors 20 Prostatic Neoplasms 19 Stomach Neoplasms 18 Recurrence 17 Multiple Myeloma 16 Neoplasm Metastasis 15 Carcinoma, Hepatocellular 15 Leukemia, Myelomonocytic, Chronic 13 Pancreatic Neoplasms 12 Lung Neoplasms 12 Solid Tumor 11 Ovarian Neoplasms 11 Uterine Cervical Neoplasms 10 Melanoma 10 Lymphoma, Large B-Cell, Diffuse 10 Sarcoma 9 Myeloproliferative Disorders 8 Colorectal Neoplasms 8 Small Cell Lung Carcinoma 7 Lymphoma, B-Cell 7 Esophageal Neoplasms 7 Biliary Tract Neoplasms 7 Triple Negative Breast Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 6

Interventions

Alpelisib 3 volagidemab 2 Metformin 2 Insulin Glargine 2 Insulin 2 Fulvestrant 2 ziprasidone 1 relacorilant 1 pembrolizumab 1 olaparib 1 exemestane 1 dapagliflozin 1 Vildagliptin 1 Tamoxifen 1 Standard of Care 1 Olanzapine 1 Letrozole 1 Insulin Lispro 1 Injections 1 Electrocardiography 1 DNA, Ribosomal 1 Control Groups 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02216799 2016-02-25

GLUCOSE-in-PN

King Faisal Specialist Hospital & Research Center

Phase 4 Completed

Hyperglycemia, Hyperphagia, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡